Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2026-01-26 @ 5:25 AM
Study NCT ID:
NCT03468218
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-05
First Post:
2018-03-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer
Sponsor:
Organization: